Hims & Hers Health Inc Ordinary Shares - Class A HIMS
News
Shares of Hims & Hers, known for hair-loss treatments and Viagra, rally amid market panic
Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results
Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
Hims & Hers shares rally as forecast bumped higher and more profitability said to be ahead
Hims & Hers' stock jumps on hopes of a first profitable year, as it floats opportunities in weight loss
WeightWatchers Stock Drops 12% After Eli Lilly Launches DTC Weight-Loss Drug Service
Uber, Datadog stocks gain, Air Products shares lead S&P 500 losers and other stocks on the move
Hims and Hers narrows loss, raises revenue guidance for the year